-Founded by leading experts in covalent chemistry, proteomics, and computational sciences from Stanford University and Harvard Medical School -Series A financing led by Sanofi Ventures with participation from Atlas Venture,… The post Matchpoint Therapeutics launches with $100 million to deliver on the promise of precision covalent medicines for immune diseases appeared first on Matchpoint Therapeutics .